Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Addimmune Logo
Addimmune CB Rank
922107
Heat Score
1
Addimmune is a clinical-stage gene and cell therapy company developing a functional cure for HIV.
Founded
obfuscation
Private Rockville, Maryland, United States11-50 www.addimmune.com/
Biotechnology
Clinical Trials
Medical
Pharmaceutical
Overview

Addimmune
Heat Score
1

Growth Score
pts
in past quarter
Heat Score 1
-60 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Addimmune

CB Rank
922107
Addimmune is a clinical-stage gene and cell therapy company developing a functional cure for HIV.
Founded
obfuscation
Private Rockville, Maryland, United States11-50 www.addimmune.com/
Biotechnology
Clinical Trials
Medical
Pharmaceutical

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Jeff Galvin
About the Company
Addimmune is a clinical-stage gene and cell therapy company developing a functional cure for HIV. It is developing a single-dose lentiviral-based autologous cell therapy.
Phone Number (301) 337-2100
Contact Email info@addimmune.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AGT103-T
A single-infusion gene and cell therapy designed to provide durable remission from HIV by genetically modifying a patient's T cells to resist HIV infection and enhance immune response.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

1,573
2,437.1%
 in past month

IT Spend

$205.2KThis year, Addimmune is projected to spend $205.2K on IT, according to Aberdeen.

Active Website Tech Count

47Addimmune is actively using 47 technologies for its website, according to BuiltWith. These include SSL by Default, IPhone / Mobile Compatible, and  Viewport Meta.
Sub-Organizations
Frequently Asked Questions

Where is Addimmune's headquarters? Addimmune is located in Rockville, Maryland, United States.Who are Addimmune's competitors? Alternatives and possible competitors to Addimmune may include Gilead Sciences, ViiV Healthcare, and  Vir Biotechnology.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|